These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 34148219)
21. Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements. Sievers H; Joos A; Hiligsmann M Int J Technol Assess Health Care; 2021 Feb; 37():e40. PubMed ID: 33622423 [TBL] [Abstract][Full Text] [Related]
22. Use of Real-World Evidence for Drug Regulatory Decisions in China: Current Status and Future Directions. Li P; Wang S; Chen Y Ther Innov Regul Sci; 2023 Nov; 57(6):1167-1179. PubMed ID: 37624556 [TBL] [Abstract][Full Text] [Related]
23. Using Real-World Data in the Health Technology Assessment of Pharmaceuticals: Strengths, Difficulties, and a Pragmatic Way Forward. Akehurst R; Murphy LA; Solà-Morales O; Cunningham D; Mestre-Ferrandiz J; de Pouvourville G Value Health; 2023 Apr; 26(4S):11-19. PubMed ID: 36706952 [TBL] [Abstract][Full Text] [Related]
24. Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making? Capkun G; Corry S; Dowling O; Asad Zadeh Vosta Kolaei F; Takyar S; Furtado C; Jónsson P; Kleinermans D; Lambert L; Schiel A; Facey K Int J Technol Assess Health Care; 2022 Nov; 38(1):e79. PubMed ID: 36321447 [TBL] [Abstract][Full Text] [Related]
25. Regulatory Approval With Real-World Data From Regulatory Science Perspective in Japan. Maeda H; Ng DB Front Med (Lausanne); 2022; 9():864960. PubMed ID: 35492312 [TBL] [Abstract][Full Text] [Related]
26. Use of Clinical Data Interchange Standards Consortium (CDISC) Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey. Facile R; Muhlbradt EE; Gong M; Li Q; Popat V; Pétavy F; Cornet R; Ruan Y; Koide D; Saito TI; Hume S; Rockhold F; Bao W; Dubman S; Jauregui Wurst B JMIR Med Inform; 2022 Jan; 10(1):e30363. PubMed ID: 35084343 [TBL] [Abstract][Full Text] [Related]
27. Comparison of two assessments of real-world data and real-world evidence for regulatory decision-making. Yuan L; Rahman M; Concato J Clin Transl Sci; 2024 Jan; 17(1):e13702. PubMed ID: 38093484 [TBL] [Abstract][Full Text] [Related]
28. Current status of real-world big data research in the cardiovascular field in Japan. Tonegawa-Kuji R; Kanaoka K; Iwanaga Y J Cardiol; 2023 Mar; 81(3):307-315. PubMed ID: 36126909 [TBL] [Abstract][Full Text] [Related]
29. Use of real-world evidence in regulatory decisions for rare diseases in the United States-Current status and future directions. Wu J; Wang C; Toh S; Pisa FE; Bauer L Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1213-1218. PubMed ID: 32003065 [TBL] [Abstract][Full Text] [Related]
30. A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Vaghela S; Tanni KA; Banerjee G; Sikirica V Orphanet J Rare Dis; 2024 Mar; 19(1):117. PubMed ID: 38475874 [TBL] [Abstract][Full Text] [Related]
31. Real-World Evidence: A Primer. Dang A Pharmaceut Med; 2023 Jan; 37(1):25-36. PubMed ID: 36604368 [TBL] [Abstract][Full Text] [Related]
32. Bridging Real-World Data Gaps: Connecting Dots Across 10 Asian Countries. Julian GS; Shau WY; Chou HW; Setia S JMIR Med Inform; 2024 Aug; 12():e58548. PubMed ID: 39026427 [TBL] [Abstract][Full Text] [Related]
33. Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews. Polisena J; Jayaraman G Int J Technol Assess Health Care; 2020 Dec; 36(6):579-584. PubMed ID: 33161916 [TBL] [Abstract][Full Text] [Related]
34. The role of Real-World Data and evidence in oncology medicines approved in EU in 2018-2019. Eskola SM; Leufkens HGM; Bate A; De Bruin ML; Gardarsdottir H J Cancer Policy; 2023 Jun; 36():100424. PubMed ID: 37116794 [TBL] [Abstract][Full Text] [Related]
35. Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal. Pongiglione B; Torbica A; Blommestein H; de Groot S; Ciani O; Walker S; Dams F; Blankart R; Mollenkamp M; Kovács S; Tarricone R; Drummond M Int J Technol Assess Health Care; 2021 Apr; 37(1):e62. PubMed ID: 33896433 [TBL] [Abstract][Full Text] [Related]
36. Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulation. Breckenridge AM; Breckenridge RA; Peck CC Br J Clin Pharmacol; 2019 Sep; 85(9):1874-1877. PubMed ID: 31290181 [TBL] [Abstract][Full Text] [Related]
37. Harnessing Real-World Data for Regulatory Use and Applying Innovative Applications. Zou KH; Li JZ; Imperato J; Potkar CN; Sethi N; Edwards J; Ray A J Multidiscip Healthc; 2020; 13():671-679. PubMed ID: 32801731 [TBL] [Abstract][Full Text] [Related]
38. Real world data and data science in medical research: present and future. Togo K; Yonemoto N Jpn J Stat Data Sci; 2022; 5(2):769-781. PubMed ID: 35437515 [TBL] [Abstract][Full Text] [Related]
39. Appropriate Relevancy and Reliability of Real-World Data for the Utilization of Regulatory Submission. Bando H; Misumi T; Sakamoto Y; Takeda Y; Nakamura Y; Mizuguchi K; Aoyagi Y; Miki I; Kuroda T; Kasai R; Suzuki T; Yoshino T; Ohtsu A Clin Colorectal Cancer; 2024 Jun; 23(2):111-117. PubMed ID: 38679555 [TBL] [Abstract][Full Text] [Related]
40. [The application of real-world evidence in drug regulatory decision-making]. Wicherski J; Haenisch B Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2024 Feb; 67(2):149-154. PubMed ID: 38214723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]